In this study, we explored the upstream regulatory mechanisms underlying inflammation-induced mitochondrial dysfunction in microglial BV-2 cells. an effective treatment for neuroinflammation. HOXD10-regulated glial-mesenchymal transition. Transmission Transduct Target Ther. 2018; 3:33. 10.1038/s41392-018-0033-6 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 12. Mehra P, Guo Y, Nong Y, Lorkiewicz P, Nasr M, Li Q, Muthusamy S, Bradley JA, Bhatnagar A, Wysoczynski M, Bolli R, Hill BG. Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair. Basic Res Cardiol. 2018; 113:46. 10.1007/s00395-018-0703-0 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 13. Zhou H, Zhang Y, Hu S, Shi C, Zhu P, Ma Q, Jin Q, Cao F, Tian F, Chen Y. Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis. J Pineal Res. 2017; 63:63. 10.1111/jpi.12413 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 14. Zhang M, Zhang Y, Xu E, Mohibi S, de Anda DM, Jiang Y, Zhang J, Chen X. Rbm24, a target of p53, is necessary for proper expression of p53 and heart development. Cell Death Differ. 2018; 25:1118C30. 10.1038/s41418-017-0029-8 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 15. Zhou H, Li N, Yuan Y, Jin YG, Guo H, Deng W, Tang QZ. Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target. Basic Res Cardiol. 2018; 113:37. 10.1007/s00395-018-0698-6 [PubMed] [CrossRef] [Google Scholar] 16. He X, Zhang J, Li C, Zhang Y, Lu Y, Zhang Y, Liu L, Ruan C, Chen Q, Chen X, Guo Q, Sun T, Cheng J, Jiang C. Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple unfavorable breast malignancy therapy. Theranostics. 2018; 8:4884C97. 10.7150/thno.27581 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 17. Zhou H, Zhu P, Guo J, Hu N, Fusicoccin Wang S, Li D, Hu S, Ren J, Cao F, Chen Y. Ripk3 induces mitochondrial apoptosis via Notch1 inhibition of FUNDC1 mitophagy in cardiac IR injury. Redox Biol. 2017; 13:498C507. 10.1016/j.redox.2017.07.007 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 18. Fisher AB, Vasquez-Medina JP, Dodia C, Sorokina EM, Tao JQ, Feinstein SI. Peroxiredoxin 6 phospholipid hydroperoxidase activity in the repair of peroxidized cell membranes. Redox Biol. 2018; 14:41C46. 10.1016/j.redox.2017.08.008 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 19. Fusicoccin Prez-Gonzlez A, Casta?eda-Arriaga R, lvarez-Idaboy JR, Reiter RJ, Galano A. Melatonin and its metabolites as chemical brokers capable of directly fixing oxidized DNA. J Pineal Res. 2019; 66:e12539. 10.1111/jpi.12539 [PubMed] [CrossRef] [Google Scholar] 20. Jin Q, Li R, Hu N, Xin T, Zhu P, Hu S, Ma S, Zhu H, Ren J, Zhou H. DUSP1 alleviates cardiac ischemia/reperfusion injury by suppressing the Mff-required mitochondrial fission and Bnip3-related mitophagy via the JNK pathways. Redox Biol. 2018; 14:576C87. 10.1016/j.redox.2017.11.004 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 21. Zhou H, Wang S, Zhu P, Hu S, Chen Y, Ren J. Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission. Redox Biol. 2018; 15:335C46. 10.1016/j.redox.2017.12.019 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 22. Chen YC, Cheng TH, Lin WL, Fusicoccin Chen CL, Yang WY, Blackstone C, Chang CR. Srv2 Is usually a Pro-fission Factor that Modulates Yeast Mitochondrial Morphology and Respiration by Regulating Actin Assembly. iScience. 2019; 11:305C317. 10.1016/j.isci.2018.12.021 [PMC free article] [PubMed] [CrossRef] [Google Scholar] 23. Lee HJ, Kang MG, Cha HY, Kim YM, Lim Y, Yang SJ. Effects of Piceatannol and Resveratrol on Sirtuins and Hepatic Inflammation in High-Fat Diet-Fed Mice. J Med Food. 2019; 22:833C40. 10.1089/jmf.2018.4261 [PubMed] [CrossRef] [Google Scholar] 24. Boniakowski AM, denDekker AD, Davis FM, Joshi A, Kimball AS, Schaller M, Allen R, Bermick J, Nycz D, Skinner ME, Robinson S,.
